An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Автор: | Bristy, Israt Zerin |
---|---|
Інші автори: | Kabir, Md. Tanvir |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2021
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/15619 |
Схожі ресурси
-
Molecules associated with the development of lung cancer
за авторством: Rahman, Adree, та інші
Опубліковано: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
за авторством: Shabnam, Musharrat
Опубліковано: (2018) -
Immunotherapy in the Management of Lung Cancer
за авторством: Tasnim, Humayra
Опубліковано: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
за авторством: Paul, Pulock
Опубліковано: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
за авторством: Mim, Shanzida
Опубліковано: (2023)